Impact of pre-existing MSP1<sub>42</sub>-allele specific immunity on potency of an erythrocytic <it>Plasmodium falciparum</it> vaccine
<p>Abstract</p> <p>Background</p> <p>MSP1 is the major surface protein on merozoites and a prime candidate for a blood stage malaria vaccine. Preclinical and seroepidemiological studies have implicated antibodies to MSP1 in protection against blood stage parasitaemia an...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-09-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | http://www.malariajournal.com/content/11/1/315 |